Trials / Completed
CompletedNCT01230541
Effect of Udenafil on Spermatogenesis
Effect of Udenafil on Spermatogenesis: A Double-blind, Randomized, Placebo-controlled, Parallel-group Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 239 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Male
- Age
- 25 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
Detailed description
Safety Study in male subjects with no or mild ED (erectile dysfunction)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Daily, oral tablet |
| DRUG | Udenafil | Daily tablet |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2010-10-29
- Last updated
- 2011-11-30
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01230541. Inclusion in this directory is not an endorsement.